This site is intended for healthcare professionals. Not a healthcare professional? Visit Mill-Klinika

Statement prepared by the Health Food Manufacturers’ Association (HFMA) in response to Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function” (The AREDS2 Randomized Clinical Trial) by Emily Y. Chew,

 this study used a formulation which was high in EPA but had a relatively low dose of DHA (350mg), whereas the scientific consensus is that DHA is the key fatty acid for prevention of cognitive decline. Previous studies that have demonstrated a benefit in this…